Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17182161 | 0.85 | — | — | |
| SCHEMBL7764140 | 0.77 | LMNA (0.34) | — | |
| SCHEMBL27094192 | 0.75 | — | — | |
| SCHEMBL27094014 | 0.75 | — | — | |
| SCHEMBL27094021 | 0.75 | — | — | |
| SCHEMBL27094075 | 0.75 | — | — | |
| SCHEMBL24245271 | 0.72 | F2 (0.44) | POLB | |
| SCHEMBL17372971 | 0.70 | — | — | |
| SCHEMBL6820158 | 0.69 | — | — | |
| SCHEMBL26644862 | 0.64 | RAB9A (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 998 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4696687-A1 | INTERMEDIATE COMPOUNDS OF PILOCARPINE AND PREPARATION METHOD THEREFOR | Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) | 2026-02-18 | — | — | EP | claimed |
| US-20250352656-A1 | SYNTHETIC CATIONIC PEPTIDOMIMETICS, THEIR DERIVATIVES AND PREPARATION THEREOF ALONG WITH COMPOSITIONS FOR VARIOUS MEDICAL APPLICATIONS | PEPTOMER THERAPEUTICS PRIVATE LTD (IN) | 2025-11-20 | — | — | US | claimed |
| EP-4126862-B1 | PROCESS FOR PREPARING A COT INHIBITOR COMPOUND | GILEAD SCIENCES INC (US) | 2025-05-21 | — | — | EP | claimed |
| EP-4525827-A1 | SYNTHETIC CATIONIC PEPTIDOMIMETICS, THEIR DERIVATIVES AND PREPARATION THEREOF ALONG WITH COMPOSITIONS FOR VARIOUS MEDICAL APPLICATIONS | Peptomer Therapeutics Private Limited (IN) | 2025-03-26 | — | — | EP | claimed |
| US-20250069948-A1 | DEPOSITION OF METALS IN RECESSED FEATURES WITH THE USE OF HALOGEN-CONTAINING DEPOSITION INHIBITORS | LAM RESEARCH CORPORATION (US) | 2025-02-27 | — | — | US | claimed |
| CN-119342971-A | ABX (ABX)3Metal halide perovskite film, preparation method and photovoltaic device | 南京工业大学 | 2025-01-21 | — | — | CN | claimed |
| US-12150941-B2 | Process for preparing substituted pyrazolo[1,5-a]pyrazines | Sumitomo Pharma Co., Ltd. (JP) | 2024-11-26 | — | — | US | claimed |
| EP-4448831-A1 | DEPOSITION OF METALS IN RECESSED FEATURES WITH THE USE OF HALOGEN-CONTAINING DEPOSITION INHIBITORS | Lam Research Corporation (US) | 2024-10-23 | — | — | EP | claimed |
| US-20240336607-A1 | PREPARATION METHOD FOR HEPATITIS B VIRUS NUCLEOCAPSID INHIBITOR | SHANGHAI ZHIMENG BIOPHARMA, INC. (CN) | 2024-10-10 | — | — | US | claimed |
| CN-118619818-A | Method for selectively activating C-H bond of aromatic alcohol derivative | 浙江九洲药业股份有限公司 | 2024-09-10 | — | — | CN | claimed |
| US-20060004067-A1 | N-(2-chloro-6-methylphenyl)-2-(6-(4-(3-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; high efficiency, high yield process to get 2-aminothiazole-5-carboxamides using halogention reaction; by-products inhibition; anticancer, psoriasis | BRISTOL-MYERS SQUIBB COMPANY | 2006-01-05 | — | — | US | claimed |
| US-20050215795-A1 | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2005-09-29 | — | — | US | claimed |
| WO-2005077945-A2 | PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-08-25 | — | — | WO | claimed |
| EP-1487859-A2 | PROCESS TO PREPARE EPLERENONE | PHARMACIA & UPJOHN COMPANY (US) | 2004-12-22 | — | — | EP | claimed |
| US-20030232981-A1 | Contacting a Delta 3,5-3-enol ether of formula (alkyl enol ether) with a hydride abstractor and an alcohol | PHARMACIA & UPJOHN COMPANY | 2003-12-18 | — | — | US | claimed |
| WO-2003082895-A2 | PROCESS TO PREPARE EPLERENONE | PHARMACIA & UPJOHN COMPANY (US) | 2003-10-09 | — | — | WO | claimed |
| WO-2001072704-A1 | AZETIDINONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND A METHOD FOR PRODUCING 1-β-ALKYL AZETIDINONE USING THE SAME | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2001-10-04 | — | — | WO | claimed |
| US-4212937-A | NITROGEN-CONTAINING HETEROCYCLIC BASE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | claimed |
| US-4032348-A | METHOD FOR FORMING PHASE HOLOGRAMS | FUJI PHOTO FILM CO., LTD. (JA) | 1977-06-28 | — | — | US | claimed |
| US-3948659-A | BLEACHING | FUJI PHOTO FILM CO., LTD. (JA) | 1976-04-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352656-A1 | SYNTHETIC CATIONIC PEPTIDOMIMETICS, THEIR DERIVATIVES AND PREPARATION THEREOF ALONG WITH COMPOSITIONS FOR VARIOUS MEDICAL APPLICATIONS | NOD2, NGLY1, CGAS | POLB 3084/4885 |
| US-20060004067-A1 | N-(2-chloro-6-methylphenyl)-2-(6-(4-(3-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; high efficiency, high yield process to get 2-aminothiazole-5-carboxamides using halogention reaction; by-products inhibition; anticancer, psoriasis | TYK2, BRAF, ERBB2 | POLB 2429/4885 |
| US-12150941-B2 | Process for preparing substituted pyrazolo[1,5-a]pyrazines | CYP3A5, CYP2F1, CYP4Z1 | POLB 2334/4885 |
| US-20050215795-A1 | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors | MAP3K5, MAP3K2, MAP3K20 | POLB 4131/4885 |
| US-20030232981-A1 | Contacting a Delta 3,5-3-enol ether of formula (alkyl enol ether) with a hydride abstractor and an alcohol | NR3C2, HSD3B2, HSD11B2 | POLB 4076/4885 |
| US-20240336607-A1 | PREPARATION METHOD FOR HEPATITIS B VIRUS NUCLEOCAPSID INHIBITOR | NUP188, SAMHD1, POLB | POLB 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.